1. Diaz-Ortiz, Maria E, Seo, Yunji, Posavi, Marijan, Weintraub, Daniel, Chen-Plotkin, Alice S. 2022. GPNMB confers risk for Parkinson's disease through interaction with α-synuclein. In Science (New York, N.Y.), 377, eabk0637. doi:10.1126/science.abk0637. https://pubmed.ncbi.nlm.nih.gov/35981040/
2. Zhang, Qiming, He, Yao, Luo, Nan, Ren, Xianwen, Zhang, Zemin. . Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. In Cell, 179, 829-845.e20. doi:10.1016/j.cell.2019.10.003. https://pubmed.ncbi.nlm.nih.gov/31675496/
3. Neal, Matthew L, Boyle, Alexa M, Budge, Kevin M, Safadi, Fayez F, Richardson, Jason R. 2018. The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor. In Journal of neuroinflammation, 15, 73. doi:10.1186/s12974-018-1100-1. https://pubmed.ncbi.nlm.nih.gov/29519253/
4. Liguori, M, Digifico, E, Vacchini, A, Allavena, P, Belgiovine, C. 2020. The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33. In Cellular & molecular immunology, 18, 711-722. doi:10.1038/s41423-020-0501-0. https://pubmed.ncbi.nlm.nih.gov/32728200/
5. Lazaratos, Anna-Maria, Annis, Matthew G, Siegel, Peter M. 2022. GPNMB: a potent inducer of immunosuppression in cancer. In Oncogene, 41, 4573-4590. doi:10.1038/s41388-022-02443-2. https://pubmed.ncbi.nlm.nih.gov/36050467/
6. Suda, Masayoshi, Shimizu, Ippei, Katsuumi, Goro, Nakanishi-Matsui, Mayumi, Minamino, Tohru. 2021. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. In Nature aging, 1, 1117-1126. doi:10.1038/s43587-021-00151-2. https://pubmed.ncbi.nlm.nih.gov/37117524/
智鼠故事 
